Pfizer, Inc.

Canada expected to finish review of first COVID-19 shot for youngest kids in weeks
Deputy Chief Public Health Officer Howard Njoo told a news conference this morning that Health Canada continues to review Moderna's application for a vaccine to protect children between six months and five years old.
FDA advisers consider Moderna's COVID shots for older kids
If the panel endorses the shot and the FDA agrees, it would become the second option for those children, joining Pfizer's vaccine.

Not like 'someone asking for Ivermectin': Doc who gave COVID jab to kids under 5 says parents knew what they were asking for

Over a three-month period in 2021, Dr. Christopher Sun administered the Pfizer COVID-19 vaccine to more than 500 children under the age of five.
Pfizer to spend $11.6B on migraine treatment maker Biohaven

Pfizer will pay $148.50 in cash for each share of Biohaven, which makes Nurtec ODT for treating and preventing migraines and has a nasal spray under development.
Paxlovid not effective for post-exposure prophylactic use in clinical trial

Reserve Paxlovid for treatment of mild-to-moderate COVID-19 in adults at high risk of progressing to severe disease.
Moderna prepares to seek Health Canada COVID-19 vaccine approval for kids under 6

To date, Health Canada has only approved mRNA COVID-19 vaccines for children over the age of five.
Pfizer COVID-19 vaccine 'grey-cap' vials that do not require dilution coming soon

Health Canada has approved an alternative to the original Pfizer COVID-19 vaccine “purple-cap” vials, for individuals 12 years of age or older.
Pfizer Canada recalls high blood pressure medication Accuretic

Pfizer says the recall is due to impurities of nitrosamine (N-nitroso-quinapril) above the accepted level.
Addressing the global antiviral deficit

In the rush to acquire vaccines, Canada overlooked the need to simultaneously create an antiviral development strategy. We need to make up for lost time.
Study: more dialysis patients saw strong antibody response with Moderna vaccine

Canada expected to finish review of first COVID-19 shot for youngest kids in weeks

FDA advisers consider Moderna's COVID shots for older kids

Not like 'someone asking for Ivermectin': Doc who gave COVID jab to kids under 5 says parents knew what they were asking for

Pfizer to spend $11.6B on migraine treatment maker Biohaven

Paxlovid not effective for post-exposure prophylactic use in clinical trial

Moderna prepares to seek Health Canada COVID-19 vaccine approval for kids under 6

Pfizer COVID-19 vaccine 'grey-cap' vials that do not require dilution coming soon

Pfizer Canada recalls high blood pressure medication Accuretic

Addressing the global antiviral deficit

Study: more dialysis patients saw strong antibody response with Moderna vaccine